September 13, 2023 | Raleigh, North Carolina,
US Eastern Daylight Time
Startup Springboard Presentations
2021 participating startup presentations are available to view on demand.
Aeon Respire
Aeon Respire is an asset-centric startup founded by former Amgen scientists and focused on advancing an innovative inhaled treatment for severe asthma, COPD, PAH, CF and viral infections including coronavirus. Our lead program represents an entirely new and advantageous approach to opening airways compared to standard of care drugs, which are based on mechanisms that have not changed for over 50 years. We have non-dilutive NIH funding and partnerships in place to reach the clinic quickly.
Website: www.aeonrespire.com
Aevum Therapeutics
Aevum Therapeutics is dedicated to the development of drugs treating neurodegenerative disorders. It has long been shown that exercise slows cognitive decline and reduces the risk for dementia along with many other health benefits. Thus, we strongly believe that harbors untapped potential for therapeutic discovery and are developing irisin, an exercise-induced peptide with strong neuroprotective effects, as our flagship therapeutic for the treatment of Alzheimer's, Parkinson's, and ALS.
Altomics Datamation
This machine learning and AI software analytics company offers a cloud-based platform of innovative and knowledge-creating tools for biomedical researchers in both academic and industrial settings around the globe. We approach deep learning powered precision medicine with our Knowledge Engine and Virtual Information Network (KEVIN) and a strategic focus on proteome-dense lipoproteins (PDL). KEVIN is a proprietary multi-omics TypeDB databases and integrated novel 3i bioinformatics apps.
Website: http://altomicsdatamation.com
Antapodia Therapeutics, Inc.
Antapodia Therapeutics is a science-driven and developmental-stage biopharmaceutical company providing breakthrough solutions for treating aggressive human cancers. The company leverages next-generation nanocarrier and gene-therapy technologies to develops first-in-class invadopodia-targeted siRNA and antibody therapies. These novel therapeutics have shown dramatic therapeutic efficacy in different types of cancers and are expected to have a high opportunity of clinical success.
Website: www.antapodia.com
ARDAN PHARMA
ARDAN PHARMA have characterized TORID as a relevant checkpoint in inflammasome activation that can be pharmacologically modulated to improve immunotherapies and target therapies clinical outcome.
Website: www.ardan-pharma.com
BIOTTS S.A.
BIOTTS S.A. is a Polish biotechnological company that develops proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology, and autoimmune diseases. The team of Biotts technologists has developed a proprietary technology for obtaining a universal transdermal therapeutic system: MTC-Y.
Website: https://biotts.com/en/
Celestial Therapeutics Inc.
Celestial is using the body's own defense in a completely novel fashion to cure a common cold, influenza, respiratory syncytial viral infections & inflammation, prevent pandemics and save lives while significantly lowering Medicare costs. Our world-class scientific team has generated solid safety and efficacy data against multiple viruses in various animal models. We are about 3 years away from establishing proof of concept in humans and a potential blockbuster deal with a major pharma company.
Website: www.celestialtherapeutics.com
Innsightful
Innsightful provides an integrated end-to-end digital health solution to help people manage and cure their mental health issues through a wearable and an app. It has filed 4 patents on it technology and is currently deploying with two universities as well as some of its 50K+ Instagram followers.
Website: https://www.innsightful.com/
Keystonemab B.V.
Keystonemab (KSM) is an AI company using IBMs Watson tools for our established platform.
We have developed and are developing specialized crawlers to gather relevant data from public domain life science websites and biggest scientific repositories on the internet.
Our platform classifies data into relevant categories to have unique insights from the complete data set like into drugs relation with biomarkers in the broader sense and those biomarkers with diseases and indications.
Website: http://keystonemab.com/
Logomix Inc.
Logomix's core competence is Geno-Writing™ platform: a collective knowledge and technologies that enable Mb-scale design and re-construction of human and the other mammalian genomes to create newly functionalized cells. Currently, Logomix provides human model cells of diseases that are caused (or are hypothesized to be caused) by larger chromosomal structural modification than simple indels, such as triplet repeat diseases and pathogenic CNVs.
Website: https://www.logomixgenomics.com/
Mirodia Therapeutics
Mirodia Therapeutics is a NewCo whose mission is to develop topical disease-modifying regenerative medicines for olfactory loss / dysfunction (anosmia / hyposmia). Anosmia / hyposmia are associated with increased morbidity & mortality & represent a potentially new and significant category for which there are no approved disease-modifying therapeutics. Mirodia Therapeutics provides a unique opportunity to establish a leadership position in addressing this significant unmet clinical need.
Website: https://www.mirodiatx.com/
Nano PharmaSolutions, Inc.
Nano PharmaSolutions, Inc. (a Delaware Co.) is a platform technology company focused on proprietary nanotechnology for improving bioavailability of poorly soluble drugs. Over 40% of generic drugs and > 70% of new drug candidates are insoluble & improving the solubility of drugs directly impacts the bioavailability. We use patent-pending physical nanotechnology to generate nano particles of small molecule drugs with NO added chemicals or solvents. Our customers are preclinical stage Pharma Co.
Website: www.nanopharmasolutions.com
NEUREVO
NEUREVO is revolutionizing neurological treatments. NEUREVO is a newly founded company, a spin-off from the very well recognized University of Munich. We are an international team of four people with different backgrounds located in Munich. Our mission is to develop first-in-class neuroprotective treatments that effectively protect against multiple neurological disorders. This includes neurodegenerative diseases like ALS or Parkinson's disease and stroke.
Website:
OncoXome, Inc.
OncoXome was founded in January 2021, incorporated as a Delware C corp, and currently located in Los Angeles, California. We are an oncology startup whose objective is to bring to patients with advanced cancer an innovative multitarget therapeutic approach hacking cell communication and using gene editing to overcome cancer resistance.
Website: http://oncoxome.com
Parallel
Powered by genomics, Parallel is a skin microbiome company that aims to redefine and improve skin health through precision formulations and cutting-edge microbial diagnostics
Website: www.parallelhealth.io
Resurge Therapeutics
Novel, minimally invasive intraprostatic drug therapy for benign prostate hyperplasia (i.e. enlarged prostate) by an experienced team in drug delivery and urology.
Website: www.resurgetherapeutics.com
Salvé Therapeutics
We are a life science tech company currently based in Bristol, ME specializing in developing software for the bioengineering of novel viral-mediated gene therapies for the treatment and cure of inherited and acquired genetic disorders.
Website: https://www.salvetx.com/